enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Direct-to-consumer advertising - Wikipedia

    en.wikipedia.org/wiki/Direct-to-consumer_advertising

    In 2008 a new resolution from ANVISA (Control Agency for Sanitary Vigilance), Resolution 96 from December 17 was released, with focus on medication advertisements. It allows direct-to-consumer advertising of non-prescription medication, with restrictions on the type of drug and words and images that can be used, among other things. [15]

  3. Marketing of off-label use - Wikipedia

    en.wikipedia.org/wiki/Marketing_of_off-label_use

    In 1993, the FDA approved gabapentin, marketed by Pfizer under the name "Neurontin", only for treatment of seizures.Pfizer subsidiary Warner-Lambert illegally used scientific activities, including continuing medical education and research, to commercially promote gabapentin, so that within five years the drug was being widely used for the off-label treatment of pain and psychiatric conditions ...

  4. Virginia State Pharmacy Board v. Virginia Citizens Consumer ...

    en.wikipedia.org/wiki/Virginia_State_Pharmacy...

    The Commonwealth of Virginia had a statute which prohibited pharmacists from advertising prescription drug prices, providing that those who did would be guilty of "unprofessional conduct". [2] Drug prices varied throughout the state, as the District Court found. [ 1 ]

  5. Prescription Drug Marketing Act - Wikipedia

    en.wikipedia.org/wiki/Prescription_Drug...

    The Prescription Drug Marketing Act (PDMA) of 1987 (P.L. 100-293, 102 Stat. 95) is a law of the United States federal government.It establishes legal safeguards for prescription drug distribution to ensure safe and effective pharmaceuticals and is designed to discourage the sale of counterfeit, adulterated, misbranded, sub potent, and expired prescription drugs.

  6. Pfizer CEO blasts America's drug pricing system: 'We have a ...

    www.aol.com/finance/pfizer-ceo-blasts-americas...

    Prescription drug prices have become a key target of criticism by those calling for reforms to the U.S. health care system. Upon taking office, President Biden vowed to lower these prices.

  7. Biogen drops Alzheimer's drug Aduhelm, ending a 17-year ... - AOL

    www.aol.com/news/biogen-discontinue-development...

    Biogen had already abandoned commercialization of the drug in 2022 after a decision by the U.S. Medicare health insurance program fo Biogen drops Alzheimer's drug Aduhelm, ending a 17-year chapter ...

  8. List of off-label promotion pharmaceutical settlements

    en.wikipedia.org/wiki/List_of_off-label...

    The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...

  9. Biden Administration targets drugs from J&J, Merck for ... - AOL

    www.aol.com/finance/biden-administration-targets...

    "These selected drugs accounted for $50.5 billion in total Part D gross covered prescription drug costs, or about 20%, of total Part D gross covered prescription drug costs between June 1, 2022 ...